Next Financial Group’s Sarepta Therapeutics SRPT Stock Holding History

Next Financial Group’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$153K	Buy	1,695 +66	+4%	+$5.64K	0.01%	1003
2021 Q3	$151K	Sell	1,629 -267	-14%	-$20.6K	0.01%	950
2021 Q2	$147K	Buy	1,896 +179	+10%	+$13.6K	0.01%	945
2021 Q1	$128K	Buy	+1,717	New	+$158K	0.01%	923
2020 Q4	–	Sell	-4	Closed	-$1K	–	2414
2020 Q3	$1K	Buy	+4	New	+$608	﹤0.01%	2140
2019 Q1	–	Sell	-131	Closed	-$14K	–	2080
2018 Q4	$14K	Sell	131 -169	-56%	-$21.1K	﹤0.01%	1241
2018 Q3	$48K	Buy	+300	New	+$41K	0.02%	560
2017 Q3	–	Sell	-1,200	Closed	-$40K	–	1942
2017 Q2	$40K	Buy	+1,200	New	+$39.1K	0.01%	848
2017 Q1	–	Sell	-1,000	Closed	-$27K	–	2248
2016 Q4	$27K	Hold	1,000	–	–	﹤0.01%	1237
2016 Q3	$61K	Hold	1,000	–	–	0.01%	857
2016 Q2	$19K	Buy	+1,000	New	+$18.5K	0.01%	995
2016 Q1	–	Sell	-100	Closed	-$3K	–	1851
2015 Q4	$3K	Buy	+100	New	+$3.24K	﹤0.01%	1537

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Next Financial Group's SRPT Position: Q4 2021 in Review

Next Financial Group increased its Sarepta Therapeutics (SRPT) stake by 4.1% in Q4 2021, buying an estimated $5.64K and bringing the position to 1,695 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #1003.

Next Financial Group first reported a position in SRPT in Q4 2015 and has held it in 12 quarters since. 343 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

Next Financial Group held 1,695 shares of Sarepta Therapeutics worth $153K as of Q4 2021.
Next Financial Group bought 66 Sarepta Therapeutics shares in Q4 2021, an estimated $5.64K.
Sarepta Therapeutics made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1003 holding.
Next Financial Group first reported a position in Sarepta Therapeutics in Q4 2015 and has held it in 12 quarters since.
343 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.